GALNT14 Regulates Ferroptosis and Apoptosis of Ovarian Cancer Through the EGFR/mTOR Pathway

References

• Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Torre LA , IslamiF, SiegelRL, WardEM, JemalA. Global cancer in women: burden and trends. Cancer Epidemiol. Biomarkers Prev.26(4), 444–457 (2017).
   PubMed Web of Science ®Google Scholar
• Chandra A , PiusC, NabeelMet al. Ovarian cancer: current status and strategies for improving therapeutic outcomes. Cancer Med.8(16), 7018–7031 (2019).
   PubMed Web of Science ®Google Scholar
• Ai Z , LuY, QiuS, FanZ. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism. Cancer Lett.373(1), 36–44 (2016).
   PubMed Web of Science ®Google Scholar
• Galluzzi L , VitaleI, AaronsonSAet al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ.25(3), 486–541 (2018).
   PubMed Web of Science ®Google Scholar
• Liang C , ZhangX, YangM, DongX. Recent progress in ferroptosis inducers for cancer therapy. Adv. Mater.31(51), e1904197 (2019).
   PubMed Web of Science ®Google Scholar
• Ghobrial IM , WitzigTE, AdjeiAA. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin.55(3), 178–194 (2005).
   PubMed Web of Science ®Google Scholar
• Gottesman MM , FojoT, BatesSE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer2(1), 48–58 (2002).
   PubMed Web of Science ®Google Scholar
• Dixon SJ , LembergKM, LamprechtMRet al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell149(5), 1060–1072 (2012).
   PubMed Web of Science ®Google Scholar
• Koppula P , ZhuangL, GanB. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell12(8), 599–620 (2020).
   PubMed Web of Science ®Google Scholar
• Kang R , KroemerG, TangD. The tumor suppressor protein p53 and the ferroptosis network. Free Radic. Biol. Med.133, 162–168 (2019).
   PubMed Web of Science ®Google Scholar
• Lin W , WangC, LiuGet al. SLC7A11/xCT in cancer: biological functions and therapeutic implications. Am. J. Cancer Res.10(10), 3106–3126 (2020).
   PubMed Web of Science ®Google Scholar
• Shiota M , NayaM, YamamotoTet al. Gold-nanofeve surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival. Nat. Commun.9(1), 1561 (2018).
   PubMedGoogle Scholar
• Honda K , HishikiT, YamamotoSet al. On-tissue polysulfide visualization by surface-enhanced Raman spectroscopy benefits patients with ovarian cancer to predict post-operative chemosensitivity. Redox Biol.41, 101926 (2021).
   PubMed Web of Science ®Google Scholar
• Xie Y , HouW, SongXet al. Ferroptosis: process and function. Cell Death Differ.23(3), 369–379 (2016).
   PubMed Web of Science ®Google Scholar
• Savaskan NE , UferC, KuhnH, BorchertA. Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function. Biol. Chem.388(10), 1007–1017 (2007).
   PubMed Web of Science ®Google Scholar
• Jiang L , KonN, LiTet al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature520(7545), 57–62 (2015).
   PubMed Web of Science ®Google Scholar
• Bennett EP , MandelU, ClausenH, GerkenTA, FritzTA, TabakLA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology22(6), 736–756 (2012).
   PubMed Web of Science ®Google Scholar
• Wang R , YuC, ZhaoD, WuM, YangZ. The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13. Oncol. Rep.30(2), 667–676 (2013).
   PubMed Web of Science ®Google Scholar
• Hillman JC , PugachevaEM, BargerCJet al. BORIS expression in ovarian cancer precursor cells alters the CTCF cistrome and enhances invasiveness through GALNT14. Mol. Cancer Res.17(10), 2051–2062 (2019).
   PubMed Web of Science ®Google Scholar
• Song KH , ParkMS, NanduTS, GadadS, KimSC, KimMY. GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment. Nat. Commun.7, 13796 (2016).
   PubMed Web of Science ®Google Scholar
• Beaufort CM , HelmijrJC, PiskorzAMet al. Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes. PLoS ONE9(9), e103988 (2014).
   PubMed Web of Science ®Google Scholar
• Dixon SJ , StockwellBR. The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol.10(1), 9–17 (2014).
   PubMed Web of Science ®Google Scholar
• Ali D , MohammadDK, MujahedHet al. Anti-leukaemic effects induced by APR-246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells. Br. J. Haematol.174(1), 117–126 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang Y , SwandaRV, NieLet al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat. Commun.12(1), 1589 (2021).
   PubMed Web of Science ®Google Scholar
• Hua H , KongQ, ZhangH, WangJ, LuoT, JiangY. Targeting mTOR for cancer therapy. J. Hematol. Oncol.12(1), 71 (2019).
   PubMed Web of Science ®Google Scholar
• Liu Y , LiuH, YangLet al. Loss of N-acetylgalactosaminyltransferase-4 orchestrates oncogenic microRNA-9 in hepatocellular carcinoma. J. Biol. Chem.292(8), 3186–3200 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang X , QiaoY, WuQet al. The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis. Nat. Commun.8, 15280 (2017).
   PubMed Web of Science ®Google Scholar
• Wang D , LippardSJ. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov.4(4), 307–320 (2005).
   PubMed Web of Science ®Google Scholar
• Koberle B , TomicicMT, UsanovaS, KainaB. Cisplatin resistance: preclinical findings and clinical implications. Biochim. Biophys. Acta1806(2), 172–182 (2010).
   PubMed Web of Science ®Google Scholar
• Giaccone G . Clinical perspectives on platinum resistance. Drugs59(Suppl. 4), 9–17 (2000).
   PubMed Web of Science ®Google Scholar
• Galluzzi L , SenovillaL, VitaleIet al. Molecular mechanisms of cisplatin resistance. Oncogene31(15), 1869–1883 (2012).
   PubMed Web of Science ®Google Scholar
• Guo J , XuB, HanQet al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res. Treat.50(2), 445–460 (2018).
   PubMed Web of Science ®Google Scholar
• Carraway KL 3rd , FunesM, WorkmanHC, SweeneyC. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr. Top. Dev. Biol.78, 1–22 (2007).
   PubMed Web of Science ®Google Scholar
• Park JH , NishidateT, KijimaKet al. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res.70(7), 2759–2769 (2010).
   PubMed Web of Science ®Google Scholar
• Wang H , TachibanaK, ZhangYet al. Cloning and characterization of a novel UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14. Biochem. Biophys. Res. Commun.300(3), 738–744 (2003).
   PubMed Web of Science ®Google Scholar
• Wagner KW , PunnooseEA, JanuarioTet al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med.13(9), 1070–1077 (2007).
   PubMed Web of Science ®Google Scholar
• Lin WR , YehCT. GALNT14: an emerging marker capable of predicting therapeutic outcomes in multiple cancers. Int. J. Mol. Sci.21(4), 1491 (2020).
   PubMed Web of Science ®Google Scholar
• Murugan AK . mTOR: role in cancer, metastasis and drug resistance. Semin. Cancer Biol.59, 92–111 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang L , LiuW, LiuFet al. IMCA induces ferroptosis mediated by SLC7A11 through the AMPK/mTOR pathway in colorectal cancer. Oxid. Med. Cell. Longev.2020, 1675613 (2020).
   PubMed Web of Science ®Google Scholar
• Liu Y , WangY, LiuJ, KangR, TangD. Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death. Cancer Gene Ther.28(1–2), 55–63 (2021).
   PubMed Web of Science ®Google Scholar
• Goettig P . Effects of glycosylation on the enzymatic activity and mechanisms of proteases. Int. J. Mol. Sci.17(12), 1969 (2016).
   PubMed Web of Science ®Google Scholar